top of page

MISSION: TO CONTINUOUSLY IMPROVE THE QUALITY, SAFETY, EFFECTIVENESS AND COSTS OF CARE OF CF PATIENTS AND THEIR FAMILIES
Maine Medical Center Clinical Studies and Trials
(Select a link to view trial enrollment status)
ADULT
Active Studies
-
VX16-809-120
Coming soon!:
Completed Studies
-
Inhaled denufosol
-
Inhaled aztreonam
-
Inhaled mannitol
-
Inhaled levofloxacin (MPEX 209)
-
MPEX 207
-
Infection control in outpatient CF clinics
-
iCare (I Change Adherence and Raise Expectations Study)
-
Continuous Alternating Therapy (CAT)
-
Pulmozyme with eFlow Rapid Nebulizer
-
Pseudomonas blocking antibody
-
Vertex 770/809 (TRANSPORT)
-
Parion CLEAN-CF
-
SNO6
-
Anthera Solution
-
Gallium IGNITE
-
Celtaxsys
PEDIATRIC
Active Studies
-
Savara Aerovanc AVAIL
-
TEACH-IP-15
-
Fibrosing Colonopathy in CF
-
VX16-809-120
Coming soon!:
-
GALAXY
Completed Studies
-
iCare
-
VERTEX 770
-
TIGER 2
-
TIGER 2 OLE
-
EPIC 001
-
EPIC 002
-
Infection control in outpatient CF clinics (MASC Study)
-
MPEX 207
-
MPEX 209
-
Continuous Alternating Therapy (CAT)
-
Pulmozyme with eFlow Rapid Nebulizer
-
Pseudomonas blocking antibody
-
Vertex 770/809 (TRANSPORT)
-
OPTIMIZE
-
Alcresta 497/498
-
Anthera Solution/Simplicity
bottom of page